Molly E Wickenhauser1, Raja B Khan2, Darcy Raches1, Jason M Ashford1, Giles W Robinson3, Kathryn M Russell1, Heather M Conklin4. 1. Department of Psychology, St. Jude Children's Research Hospital, Memphis, Tennessee. 2. Division of Neurology, St. Jude Children's Research Hospital, Memphis, Tennessee. 3. Division of Neuro-Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee. 4. Department of Psychology, St. Jude Children's Research Hospital, Memphis, Tennessee. Electronic address: Heather.Conklin@stjude.org.
Abstract
BACKGROUND: Despite recent efforts, disagreement remains among frontline clinicians regarding the operational definition of a syndrome commonly referred to as posterior fossa syndrome or cerebellar mutism syndrome. METHODS: We surveyed experts in the clinical care of children with posterior fossa tumors to identify trends and discrepancies in diagnosing posterior fossa syndrome. RESULTS: All surveyed professionals conceptualized posterior fossa syndrome as a spectrum diagnosis. The majority agreed that mutism is the most important symptom for diagnosis. However, results highlighted ongoing discrepancies related to important features of posterior fossa syndrome. CONCLUSIONS: Greater posterior fossa syndrome conceptual alignment among providers is needed to formulate specific diagnostic criteria that would further research and clinical care. The authors propose preliminary diagnostic criteria for posterior fossa syndrome that require refinement through careful clinical characterization and targeted empirical investigation.
BACKGROUND: Despite recent efforts, disagreement remains among frontline clinicians regarding the operational definition of a syndrome commonly referred to as posterior fossa syndrome or cerebellar mutism syndrome. METHODS: We surveyed experts in the clinical care of children with posterior fossa tumors to identify trends and discrepancies in diagnosing posterior fossa syndrome. RESULTS: All surveyed professionals conceptualized posterior fossa syndrome as a spectrum diagnosis. The majority agreed that mutism is the most important symptom for diagnosis. However, results highlighted ongoing discrepancies related to important features of posterior fossa syndrome. CONCLUSIONS: Greater posterior fossa syndrome conceptual alignment among providers is needed to formulate specific diagnostic criteria that would further research and clinical care. The authors propose preliminary diagnostic criteria for posterior fossa syndrome that require refinement through careful clinical characterization and targeted empirical investigation.
Authors: Susan Beckwitt Turkel; Lan Shu Chen; Marvin D Nelson; Douglas Hyder; Floyd H Gilles; Linda Woodall; Kenneth Braslow; C Jane Tavaré Journal: J Neuropsychiatry Clin Neurosci Date: 2004 Impact factor: 2.198
Authors: Amar Gajjar; Murali Chintagumpala; David Ashley; Stewart Kellie; Larry E Kun; Thomas E Merchant; Shaio Woo; Greg Wheeler; Valerie Ahern; Matthew J Krasin; Maryam Fouladi; Alberto Broniscer; Robert Krance; Gregory A Hale; Clinton F Stewart; Robert Dauser; Robert A Sanford; Christine Fuller; Ching Lau; James M Boyett; Dana Wallace; Richard J Gilbertson Journal: Lancet Oncol Date: 2006-10 Impact factor: 41.316
Authors: Thora Gudrunardottir; Angela T Morgan; Andrew L Lux; David A Walker; Karin S Walsh; Elizabeth M Wells; Jeffrey H Wisoff; Marianne Juhler; Jeremy D Schmahmann; Robert F Keating; Coriene Catsman-Berrevoets Journal: Childs Nerv Syst Date: 2016-05-03 Impact factor: 1.475
Authors: Cortney Wolfe-Christensen; Larry L Mullins; James G Scott; René Y McNall-Knapp Journal: Pediatr Blood Cancer Date: 2007-10-15 Impact factor: 3.167
Authors: Mariam P Korah; Natia Esiashvili; Claire M Mazewski; Roger J Hudgins; Mourad Tighiouart; Anna J Janss; Frederick P Schwaibold; Ian R Crocker; Walter J Curran; Robert B Marcus Journal: Int J Radiat Oncol Biol Phys Date: 2009-08-19 Impact factor: 7.038
Authors: Jane E Schreiber; Shawna L Palmer; Heather M Conklin; Donald J Mabbott; Michelle A Swain; Melanie J Bonner; Mary L Chapieski; Lu Huang; Hui Zhang; Amar Gajjar Journal: Neuro Oncol Date: 2017-11-29 Impact factor: 12.300
Authors: Molly E Wickenhauser; Raja B Khan; Darcy Raches; Jason M Ashford; Kathryn M W Russell; Kristin Lyons; Giles W Robinson; Amar Gajjar; Paul Klimo; Heather M Conklin Journal: J Neurooncol Date: 2022-04-05 Impact factor: 4.130